19 WiSys Technologies in "Engineering" or "Information Technology" or "Pharmaceuticals & Vitamin D" or "Research Tools" or "Food & Supplements" or "Medical Imaging"
WiSys is seeking strategic partners interested in the commercial use of this innovation.
Researchers from the University of Wisconsin - Stevens Point are part of a multi-institution research team that has developed a vaccine with proven efficacy in preventing Francisella infections in fish.
WiSys is seeking strategic partners interested in the commercial use of this innovation
WiSys is seeking a strategic partner skilled in the manufacturing and distribution of insulated storage containers or portable mini refrigerators. Ideally, this partner could provide a route to market for the commercialization and use of this retrofit Peltier cooling device.
WiSys is seeking a strategic partner skilled in the processes of metal treating and finishing who could provide a route to market for the commercialization and use of this anodizing pen.
WiSys is seeking a strategic partner interested in providing a route to market for the commercialization and use of this anthocyanin extraction system. There is also interest in partnering with a fruit processing company for the continued testing and scaling of this system.
WiSys is seeking a strategic partner skilled in the design, modeling, and fabrication of Quantum Dots and Quantum wires. There is interest in working with a partner to test the beta version of the CAE simulation tool and provide feedback when modeling both Quantum Wires and Quantum Dots. Additionally, there is interest in identifying a partner with a 3D finite element method solver for further development and testing of the CAE simulation tool.
WiSys is currently seeking strategic partners operating in the non-destructive testing industry interested in further developing this novel health monitoring system for concrete structures, ultimately providing a route to market for its commercialization.
WiSys Technology Foundation is seeking a strategic partner with an industry player in the life science tools and reagents industry for the further development and commercialization of its novel monomeric fluorescent protein.
WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.